VC/PE
Stories about how space companies are raising money to take on next-gen missions.
Impulse Space Closes $500M Series D
“Often in a fundraise like this, there’s some narrative of, ‘Okay, well, now we move into this new line of business, or now we go build the factory in Ohio,’” President and COO Eric Romo told Payload. “There’s none of that here. This is really about, ‘We need more of the same. We need to continue on the same trajectory we’re on.’”
Observable Space Raises $90M Series A
Space-tech startup Observable Space has closed a $90M Series A to boost its production of laser and optical hardware—in addition to expanding internationally beyond the US.
European Space Startups Jockey for ‘Infrastructure’ Financing
Europe has a growth-stage-capital problem.
Star Catcher Closes $65M Series A
B Capital led the round, which was co-led by Shield Capital and Cerberus Ventures.
Aetherflux Rebrands, Pivots Business—and Raises $275M
To better align with its new business, Aetherflux is rebranding to Cowboy Space Corporation.
Lunar Outpost Closes $30M Series B, Unveils New Rover
The fundraise highlights the huge demand from investors looking to capitalize on NASA’s new vision for the US presence on the Moon.
Astranis Raises $450M+, Including $300M Series E
Snowpoint Ventures and Franklin Templeton co-led the round, which valued the company at $2.8B, according to a source close to the deal.
Scout Space Closes $18M Series A
Plans for expansion include building a new satellite sensor factory outside DC, and nearly doubling Scout’s headcount in the next 18 months.
LiveEO Raises €28M+ to Fund its First Constellation
The German company will use the funds to scale its business, launch its own satellite constellation, and build the tech to meet the growing demand for EO data.
European Space Firms Raised €1.4B of Private Capital in 2025
Private European capital markets are increasingly comfortable backing space-industry upstarts.
BioOrbit Raises £9.8M Seed To Manufacture Cancer Drugs in Orbit
BioOrbit is attempting to leverage microgravity to reformulate drugs so that they can be self administered by patients instead of requiring medical staff to administer them.
True Anomaly Closes $650M Series D
True Anomaly has raised a $650M Series D, announced on the heels of its Golden Dome award for space-based interceptor tech—a new product for the four-year-old company.
UNIVITY Raises €27M Series A
Blast Club and Expansion Venture Capital contributed to the round, which also included support from the Deep Tech fund managed by Bpifrance.
